Human chorionic gonadotropin stimulates spheroid attachment on fallopian tube epithelial cells through the mitogen-activated protein kinase pathway and down-regulation of olfactomedin-1 by Cheung, ANY et al.
Title
Human chorionic gonadotropin stimulates spheroid attachment
on fallopian tube epithelial cells through the mitogen-activated
protein kinase pathway and down-regulation of olfactomedin-1
Author(s) So, KH; Kodithuwakku, SPK; Kottawatta, KSA; Li, RHW; Chiu,PCN; Cheung, ANY; Ng, EHY; Yeung, WSB; Lee, CKF
Citation Fertility and Sterility, 2015, v. 104 n. 2, p. 474-482
Issued Date 2015
URL http://hdl.handle.net/10722/214727
Rights Creative Commons: Attribution 3.0 Hong Kong License
 hCG promote implantation in oviduct   F & S 19650 style revision 1 
  2 
 Human chorionic gonadotropin stimulates spheroid attachment on 3 
Fallopian tube epithelial cells through the mitogen-activated protein 4 
kinase pathway and down-regulation of Olfactomedin-1 5 
 6 
Kam-Hei So, M.Phil.,1 Suranga P. Kodithuwakku, Ph.D.,1,2 Kottawattage S. A. 7 
Kottawatta, M.Phil.,1,3 Raymond H.W. Li, M.B.B.S., F.R.C.O.G.,1,4,5 Philip C.N. 8 
Chiu, Ph.D.,1,4,5 Annie N.Y. Cheung, M.D., F.R.C.Path.,6 Ernest H.Y. Ng, M.D., 9 
F.R.C.O.G.,1,4,5 William S.B. Yeung, Ph.D.,1,4,5 and Kai-Fai Lee, Ph.D.,1,4,5,* 10 
 11 
1Department of Obstetrics and Gynaecology, Li Ka Shing Faculty of Medicine, 12 
The University of Hong Kong, Hong Kong SAR, China 13 
2Department of Animal Science, Faculty of Agriculture, The University of 14 
Peradeniya, Peradeniya, Sri Lanka 15 
3Department of Veterinary Public Health and Pharmacology, Faculty of 16 
Veterinary Medicine and Animal Science, The University of Peradeniya, 17 
Peradeniya, Sri Lanka 18 
4Centre for Reproduction, Development and Growth, Li Ka Shing Faculty of 19 
Medicine, The University of Hong Kong, Hong Kong SAR, China 20 
5ShenZhen Key Laboratory of Fertility Regulation. The University of Hong 21 
Kong-Shenzhen Hospital, Haiyuan 1st Road, Futian District, Shenzhen, 22 
518053, China 23 
6Department of Pathology, Li Ka Shing Faculty of Medicine, The University of 24 
Hong Kong, Hong Kong SAR, China 25 
 26 
*Corresponding author: Kai-Fai Lee (PhD), Department of Obstetrics and 27 
Gynaecology, The University of Hong Kong, Pokfulam, Hong Kong. Fax: 28 
852-28161947 and E-mail: ckflee@hku.hk 29 
 30 
K.H.S. has nothing to disclose. S.P.K. has nothing to disclose. K.S.A.K. has 31 
nothing to disclose. R.H.W.L. has nothing to disclose. P.C.N.C. has nothing to 32 
disclose. A.N.Y.C. has nothing to disclose. E.H.Y.N. has nothing to disclose. 33 
W.S.B.Y. has nothing to disclose. K.F.L. has nothing to disclose. 34 
  35 
 Capsule 36 
hCG increases the attachment of trophoblastic spheroids on human Fallopian 37 
tube epithelial cells through activation of Erk and Wnt/β-catenin signaling 38 
pathways leading to down-regulation of Olfm1 expression. 39 
  40 
 Objective: To study the effect of human chorionic gonadotropin (hCG) on 41 
Olfactomedin-1 (Olfm1) expression and spheroid attachment in human 42 
Fallopian tube epithelial cells in vitro. 43 
Design: Experimental study 44 
Setting: Reproductive biology laboratory 45 
Patient(s): Healthy non-pregnant women 46 
Intervention(s): No patient interventions  47 
Main Outcome Measure(s): Luteinizing hormone/chorionic gonadotropin 48 
receptor (LHCGR) and Olfm1 expression in Fallopian tube epithelium cell line 49 
(OE-E6/E7 cells). OE-E6/E7 cells treated with hCG, U0126 Erk inhibitor or 50 
XAV939 Wnt/β-catenin inhibitor were analyzed by Western blotting, RT-PCR, 51 
and in vitro spheroid attachment assay. 52 
Result(s): hCG increased spheroid attachment on OE-E6/E7 cells through 53 
down-regulation of Olfm1 and activation of Wnt and MAPK signaling pathways. 54 
U0126 down-regulated both MAPK and Wnt/β-catenin signaling pathways and 55 
up-regulated Olfm1 expression. XAV939 down-regulated only the 56 
Wnt/β-catenin-signaling pathway but up-regulated Olfm1 expression. 57 
Conclusion(s): hCG activated both Erk and Wnt/β-catenin signaling pathways 58 
and enhanced spheroid attachment on Fallopian tube epithelial cells through 59 
down-regulation of Olfm1 expression. 60 
Key Words: Olfactomedin-1; Fallopian tube; tubal ectopic pregnancy; 61 
Wnt-signaling; MAPK signaling 62 
  63 
 Introduction 64 
 The Fallopian tube, also known as oviduct, consists of epithelial and 65 
stromal cells forming the mucosal layer, which is surrounded by a layer of 66 
smooth muscle cells. The Fallopian tube has several important functions, 67 
including transport of gametes for fertilization and transport of the developing 68 
embryo to the uterus for implantation. Ectopic pregnancies occur in 69 
approximately 2% of all pregnancies (1), of which about 70% occur in the 70 
ampullary region of the tube (2, 3).  Tubal ectopic pregnancies (TEP) may 71 
lead to complications such as tubal rupture, hemorrhage and maternal 72 
mortality. The predisposing factors for TEP were thought to be the impaired 73 
transport of the embryo in the Fallopian tube and modifications in the tubal 74 
environment favoring tubal implantation (4). Modification of the Fallopian tube 75 
environment could be induced by inflammation or modulated by signals from 76 
the embryo itself. 77 
 78 
 Human chorionic gonadotropin (hCG) is a peptide hormone secreted by 79 
the pre-implantation embryo starting from the 8-cell stage (5, 6). This 80 
heterodimeric glycoprotein is structurally similar to luteinizing hormone (LH) 81 
and can act as a luteal phase support in assisted reproduction (7). Both LH 82 
and hCG interact with the cell surface luteinizing hormone/chorionic 83 
gonadotropin receptor (LHCGR). Recent studies have suggested that hCG 84 
may play important roles during embryo implantation by modulating the 85 
maternal immune system, down-regulating anti-adhesion molecules, and 86 
controlling trophoblast invasion (8-10). However, the mechanisms by which 87 
hCG regulates embryo implantation remain largely unknown. 88 
 89 
  Functionally and biologically active LHCGRs are expressed in several 90 
tissues, including the female reproductive tract from the Fallopian tubes to the 91 
uterus (11-13). However, some studies have reported that hCG can carry out 92 
its action independent of LHCGR (14, 15). LHCGR is a G-protein coupled 93 
receptor that is capable of acting through multiple signal transduction 94 
pathways, including phospholipid-specific phospholipase C and adenylyl 95 
cyclase, which activate the mitogen-activated protein kinase (MAPK) pathway 96 
(16, 17). The MAPK pathway contains many components including 97 
extracellular signal-regulated kinase (Erk), c-Jun N-terminal kinase (JNKs), 98 
and p38. It has been reported that hCG can stimulate production of 99 
prostaglandin in endometrial epithelial cells through the phosphatidylinositol 100 
3-kinase-extracellular regulatory kinase pathway (18). Recent studies have 101 
suggested that Erk can crosstalk and regulate the Wnt/β-catenin signaling 102 
pathway, which is essential for implantation (19-21). 103 
 104 
In the Wnt/β-catenin signaling pathway, the Wnt ligand binds to the cell 105 
surface Frizzled (Fz) receptor, which is a seven-transmembrane domain 106 
receptor (22). Interaction between the Wnt ligand and Fz receptor activates 107 
Dishevelled (Dvl), which leads to inactivation of glycogen synthase kinase-3β 108 
(GSK-3β) (23). GSK-3β is one of the core components of the β-catenin 109 
destruction complex, which consists of GSK-3β, phosphorylated adenomatous 110 
polyposis coli (APC), and Axin (24). Inactivation of any of the molecules in the 111 
β-catenin destruction complex allows β-catenin to escape proteasomal 112 
degradation, resulting in cytoplasmic accumulation of β-catenin that can enter 113 
the nucleus for gene activation (25). 114 
 115 
 The Wnt/β-catenin signaling pathway has been widely studied and found 116 
to be important in normal pregnancy (26, 27). Activation of the Wnt/β-catenin 117 
signaling pathway is essential for embryo adhesion onto the endometrium, 118 
trophoblast migration, vascularization, and angiogenesis of the placenta (28). 119 
The Wnt/β-catenin signaling pathway has been found to be involved in 120 
Fallopian tube inflammation and tubal ectopic pregnancy (29). Wnt activation 121 
down-regulated olfactomedin-1 (Olfm1) in oviductal epithelial cells, resulting in 122 
a microenvironment which may predispose to TEP (30). Therefore, it is 123 
important to understand the regulation and effects of Wnt/β-catenin signaling 124 
in implantation to understand tubal ectopic pregnancy. 125 
 126 
Olfm1 expression in the endometrium is mediated by progesterone and is 127 
down-regulated during the receptive period of the cycle (31-34), which 128 
suggests the presence of Olfm1 may hinder embryo attachment. In zebrafish, 129 
Olfm1 regulated the Wnt-signaling pathway and modulated retinal axon 130 
elongation (35). Previously, we used a trophoblastic spheroid 131 
(JAr)-endometrial epithelial cell (Ishikawa) co-culture model to demonstrate 132 
the suppressive effect of Olfm1 on JAr spheroid attachment on Ishikawa cells 133 
(36). However, how Olfm1 is regulated at the feto-maternal interface remains 134 
largely unknown. 135 
 136 
We hypothesized that hCG secreted from human pre-implantation 137 
embryos can enhance embryo attachment onto Fallopian tube epithelial cells 138 
through down-regulation of Olfm1 expression in the tube. It is likely that hCG 139 
secreted from the embryo accompanied with embryo retention in the Fallopian 140 
tube may predispose to TEP. In the present study, we investigated the effect of 141 
 hCG on the attachment rate of trophoblastic spheroids on Fallopian tube 142 
epithelial cells (OE-E6/E7 cells) using a co-culture model. 143 
 144 
  145 
 Materials and Methods 146 
Study Participants 147 
Normal Fallopian tubes were collected from 15 non-pregnant women (age 148 
range, 37-51 years; mean ± SD, 42.8±4.9 years) who had undergone 149 
hysterectomy for benign gynaecological conditions at Department of 150 
Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong. All patients 151 
had regular menstrual cycles (21-30 days; mean ± SD, 26.5±3 days) and did 152 
not have history of tubal pathology. The phase of menstrual cycle of each 153 
patient sample was determined by the date of the last menstrual period. 154 
Written consent was obtained from all participants. The study was approved by 155 
the Institutional Review Board of the University of Hong Kong/Hospital 156 
Authority Hong Kong West Cluster (UW10-109) 157 
 158 
Immunohistochemistry and Histological Scoring  159 
Fallopian tube biopsies were fixed in 4% paraformaldehyde followed by 160 
70% ethanol. The biopsies were embedded in paraffin wax and sectioned at a 161 
thickness of 5 µm and mounted on polylysine-coated slides. Tissue sections 162 
were deparaffinized and rehydrated, and then subjected to antigen retrieval 163 
using Target Retrieval Solution (Dako Cytomation, Carpinteria, CA, USA). 164 
Ampullary region of Fallopian tube tissues sections were incubated with 165 
anti-β-catenin (1:200, BD610153, BD Biosciences, San Jose, California, USA), 166 
anti-LHCGR (1:200; ab125214, Abcam, Cambridge, MA, USA) and anti-Olfm1 167 
(1:50; ab71540, Abcam) antibodies for 18 h. Fallopian tube sections were 168 
incubated in 3,3’-diaminobenzidine (DAB substrate chromogen, Dako 169 
Cytomation) and the nucleus was counter-stained with Hematoxylin. Images 170 
were captured under a light microscope with a digital camera (Axioscop, Zeiss, 171 
 Göttingen, Germany). The intensity of staining of the epithelial cells in the 172 
Fallopian tube sections was quantitated by a single observer using Histological 173 
scoring (H-score) in a total of 500 cells in each section (from 4 fields with more 174 
than 100 cells in each field) as described previously (30). Results were 175 
presented as mean ± SD. 176 
 177 
Western Blotting 178 
For Western blot analysis, total protein extraction was performed by 179 
dissolving cell lysates from Fallopian tube epithelial cell line (OE-E6/E7 cells) 180 
or isolated primary Fallopian epithelial cells (37) in radioimmunoprecipitation 181 
assay (RIPA) buffer solution [1x phosphate-buffered saline (PBS), 1% Nonidet 182 
P-40, 0.5% sodium deoxycholate, 0.1% SDS] containing protease inhibitors 183 
(Calbiochem, Darmstadt, Germany). The membrane was probed with 184 
anti-Olfm1 (1:400, ab71540, Abcam), anti-active-β-catenin (1:1000, 05-665, 185 
Millipore, Billerica, MA, USA), anti-β-catenin (1:1000, BD610153, BD 186 
Biosciences), anti-Axin2 (1:1000, ab32197, Abcam), anti-phospho-Erk (1:1000, 187 
9910, Cell Signaling Technology Inc., Danvers, MA, USA), anti-Erk (1;1000, 188 
9926, Cell Signaling Technology Inc.), anti-phospho-JNK (1:1000, 9910, Cell 189 
Signaling Technology Inc.), anti-JNK (1:1000, 9926, Cell Signaling Technology 190 
Inc.), anti-phospho-p38 (1:1000, 9910, Cell Signaling Technology Inc.), and 191 
anti-p38 (1:1000, 9926, Cell Signaling Technology Inc.) antibodies in blocking 192 
solution overnight at 4oC. The membrane was washed five times in PBST for 5 193 
min and incubated with anti-rabbit or anti-mouse secondary antibody 194 
conjugated with horseradish peroxidase (1:5000, GE Healthcare, Pittsburgh, 195 
PA, USA) for 1 h. After washing five times in PBST for 5 min, the signal was 196 
visualized using an enhanced chemiluminescence reagent (Santa Cruz, Santa 197 
 Cruz). Protein levels were normalized by probing the membrane with β-actin 198 
antibody (Sigma, St Louis, MO, USA). 199 
 200 
Spheroid Co-culture Assay 201 
The spheroid attachment assay was performed as previously described 202 
(37, 38). Human trophoblastic JAr cells (blastocyst surrogate) and OE-E6/E7 203 
cells were used as the co-culture model. Trophoblastic spheroids of about 100 204 
µm in size were prepared from trypsinized JAr cells and incubated on an 205 
orbital shaker rotating at 106 rpm for 24 h at 37oC. The trophoblastic spheroids 206 
were transferred onto a confluent monolayer of hCG-treated (0.25, 2.5 or 25 207 
IU/ml) OE-E6/E7 cells (in DMEM/F12 with 10% fetal bovine serum and 1% 208 
L-glutamine) in a 12-well culture plate and incubated for 1 h at 37oC. 209 
Unattached spheroids were removed by shaking the culture plates at 140 rpm 210 
for 10 min. The attached spheroids remaining on the OE-E6/E7 monolayer 211 
were counted. The attachment rate was expressed as a percentage of the 212 
number of attached spheroids divided by the total number of spheroids added 213 
onto the OE-E6/E7 monolayer. 214 
 215 
Luciferase Reporter Assay 216 
OE-E6/E7 cells were seeded at a density of 20,000 cells per well in a 217 
24-well plate 24 h prior to transfection with 1 µg of TOPFLASH or FOPFLASH 218 
and 0.2 µg of the internal control plasmid (pRK-TK, Promega, Madison, WI, 219 
USA). TOPFLASH and FOPFLASH contain a native or mutated binding 220 
sequence for TCF/LEF, respectively, which are transcription factors in the 221 
Wnt/β-catenin signaling pathway. Transfection was carried out using 222 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Total cell extracts were 223 
 prepared for the luciferase activity assay 24 h post-transfection according to 224 
the manufacturer’s instructions (Promega). 225 
 226 
Treatment with hCG, MAPK Inhibitor or Wnt Inhibitor 227 
Both OE-E6/E7 and JAr cells were treated with hCG (0, 0.25, 2.5 and 25 228 
IU/mL) for 24 h. For the MAPK inhibitor study, OE-E6/E7 cells were treated 229 
with 0.07 μM U0126 Erk inhibitor for 15 min. For the Wnt inhibitor study, 230 
OE-E6/E7 cells were treated with 0.1 μM XAV939 Wnt inhibitor for 24 h. 231 
 232 
Statistical Analysis 233 
Statistical analysis was determined by non-parametric ANOVA on Rank 234 
test. Non-parametric Mann Whitney U test or parametric Student’s t-test were 235 
used where appropriate as the post-test. All data were presented as mean ± 236 
standard error mean (S.E.M.). Each experiment was repeated in triplicate. A 237 
p-value < 0.05 was considered statistically significant. 238 
 239 
  240 
 Results 241 
OLFM1 and LHCGR Expression in the Fallopian tube at different phases 242 
of the menstrual cycle 243 
 Olfm1 and LHCGR proteins were strongly expressed in the cytoplasm of 244 
the human Fallopian epithelial cells as detected by immunohistochemistry (Fig. 245 
1A). Olfm1 expression was significantly lower during the luteal phase of the 246 
cycle compared to the follicular and peri-ovulatory phases (Fig. 1B). In contrast, 247 
LHCGR expression in Fallopian tube epithelial cells was significantly higher 248 
during the luteal phase compared to the follicular and peri-ovulatory phases 249 
(Fig. 1B). Olfm1 and LHCGR were weakly expressed in the stromal cells of the 250 
Fallopian tube throughout all menstrual phases.  251 
 252 
Effect of hCG treatment on the attachment of JAr spheroids on OE-E6/E7 253 
cells 254 
 Spheroids of about 100 µm in size were prepared for the spheroid 255 
attachment assay (Fig. 1C). OE-E6/E7 or JAr cells were treated with different 256 
concentrations of hCG (0, 0.25, 2.5 and 25 IU/mL). OE-E6/E7 cells treated 257 
with a concentration of 25 IU/mL hCG significantly increased the attachment 258 
rate of non-treated JAr spheroid (P<0.05, Fig. 1Dtop panel). On the other hand, 259 
JAr spheroids treated with different concentrations of hCG before seeding onto 260 
the OE-E6/E7 cells untreated with hCG did not show any significant difference 261 
in attachment rate (Fig. 1D, middle panel).  OE-E6/E7 cells treated with 2.5 262 
and 25 IU/ml hCG had significantly higher attachment rate to JAr cells treated 263 
with hCG a fixed concentration of 25 IU/ml (P<0.05, Fig. 1D, bottom panel). 264 
 265 
Effect of hCG on the expressions of Olfm1 and Wnt/-catenin molecules 266 
 in OE-E6/E7 and primary Fallopian epithelial cells from tissue 267 
 OE-E6/E7 cells express hCG receptor, when OE-E6/E7 was treated with 268 
hCG (2.5 and 25 IU/mL), there was no effect on hCG receptor, but significantly 269 
decreased the Olfm1 expression (Fig. 2A). Similarly, hCG (25 IU/mL) 270 
down-regulated Olfm1 expression in primary Fallopian epithelial cells isolated 271 
from Fallopian tissue (Fig. 2B). β-catenin was localized at the epithelium of 272 
human Fallopian tube and hCG up-regulated active -catenin expression in 273 
primary Fallopian epithelial cells isolated from Fallopian tissue (Fig. 2C). hCG 274 
down-regulated Axin2 expression, but increased the ratio of 275 
active--catenin/total -catenin expressions in the OE-E6/E7 cells (Fig. 2D).  276 
The effect of hCG on Wnt-signaling activation was confirmed using the 277 
TOP/FOP Flash luciferase reporter assay. Treatment with 25 IU/mL hCG 278 
significantly increased luciferase activity in the transfected OE-E6/E7 cells (Fig. 279 
2E).  280 
 281 
Effect of Erk or Wnt inhibitors on MAPK and Wnt/-catenin signaling 282 
pathways 283 
Treatment with hCG at 2.5 and 25 IU/mL activated Erk 284 
(phosphor-Erk/Total-Erk), but not JNK (phosphor-JNK/total-JNK) or p38 285 
(phosphor-p38/Total p38) (Fig. 3A). Treatment with U0126 inactivated the Erk 286 
pathway by significantly down-regulating phospho-Erk expression, while it 287 
significantly suppressed spheroid attachment (Fig. 3B). Interestingly, U0126 288 
also down-regulated active--catenin expression in OE-E6/E7 cells. Treatment 289 
with XAV939 inactivated the Wnt/-catenin signaling pathway, while it also 290 
significantly suppressed spheroid attachment. However, there was no change 291 
in the expression of Erk signaling molecules with the XAV939 treatment. 292 
 Treatment of OE-E6/E7 cells with either U0126 or XAV939 increased Olfm1 293 
expression (Fig. 3B), but hCG could not suppress the stimulating effects of 294 
U0126 or XAV939, even though it could suppress Olfm1 expression in 295 
OE-E6/E7 cells.  296 
 Discussion 297 
 In this study, we demonstrated that human Fallopian tube epithelium and 298 
the OE-E6/E7 cell line both expressed LHCGRs. Our results suggest that 299 
OE-E6/E7 or human primary Fallopian epithelial cells treated with hCG 300 
down-regulated Olfm1 expression. hCG enhanced JAr spheroid attachment to 301 
OE-E6/E7 cells in vitro through the activation of Wnt/-catenin and Erk 302 
pathways, but not through the JNK or p38 pathways. 303 
 304 
 Accumulating evidence has suggested that retention of 305 
pre-implantation embryo, tubal inflammation, and cigarette smoking are 306 
predisposing factors leading to TEP (39). Results from the present study 307 
suggest that hCG could promote attachment of the embryo on Fallopian tube 308 
epithelial cells possibly leading to TEP. hCG can stimulate trophoblast invasion 309 
through activation of Erk1/Erk2, up-regulation of leptin expression (40), and 310 
secretion of TIMP1 in human endometrial stromal cells (41). hCG can also 311 
trigger angiogenesis through the modulation of stromal cell responsiveness to 312 
interleukin 1 (42) and can up-regulate trophinin, a cell adhesion molecule in 313 
endometrial cells (43).  314 
 315 
We found that Olfm1 expression was down-regulated at the ampullary 316 
region of the human Fallopian tube at the luteal phase of the cycle. The 317 
decreased expression of tubal Olfm1 was in agreement with our previous 318 
finding that endometrial Olfm1 was down-regulated in the secretory phase of 319 
the cycle (36), when serum progesterone level is high (44). hCG is known to 320 
be secreted by trophoblastic cells in human pre-implantation embryo. It has 321 
been reported that the trophoblastic JAr cells can secrete 0.1 IU/mL hCG in 24 322 
 h (45) and the trophoblastic spheroid can secrete <0.01 IU/mL hCG in 6 days 323 
of culture (46). We found that a high hCG level in the local microenvironment 324 
favored embryo attachment on epithelial cells in the Fallopian tubes. The 325 
upper dosage of hCG (25 IU/mL) used in this experiment was comparable to 326 
various studies, which range from 1 to 50 IU/ml (8-10). Assuming that the 327 
volume of Fallopian tube to be 1-10 µl, the concentration of hCG encountered 328 
by pre-implantation embryo in the blocked tube which could reach 617.5 ~ 61.8 329 
IU/ml (9). Results from this study may shed light on the underlying mechanism 330 
on the role of hCG in regulating Olfm1 in ectopic pregnancy. 331 
 332 
LHCGR is a G-protein coupled receptor that activates many downstream 333 
signaling pathways such as MAPK pathway (16, 17). Accumulating evidence 334 
has suggested that the MAPK pathway cross-talks with the Wnt/-catenin 335 
signaling pathway through regulation of the -catenin destruction complex, 336 
which consists of Axin2, APC and GSK3(47). We previously reported that 337 
Wnt-activation down-regulated Olfm1 in Fallopian tube epithelial cells and 338 
promoted spheroid attachment (30). To elucidate the molecular mechanism 339 
involved in the hCG-mediated attachment process, we examined whether hCG 340 
regulated the Wnt/-catenin signaling pathway. We found that -catenin was 341 
localized in the epithelial cells of the Fallopian tube and similar expression 342 
pattern was reported in mouse oviduct (48). hCG treatment up-regulated 343 
active--catenin and down-regulated Axin2 expressions. This suggests that 344 
Axin2 down-regulation could allow -catenin to enter the nucleus for the 345 
activation of gene transcription (49). Similarly, microarray profiling has also 346 
confirmed that Wnt-related genes could be activated by hCG in pre-ovulatory 347 
ovarian follicles (50). 348 
  349 
Our result showed both Erk and Wnt/β-catenin signaling pathways were 350 
activated by hCG. However, it was still unknown if the MAPK pathway was 351 
upstream or downstream of Wnt/-catenin signaling pathway. Accordingly, we 352 
treated OE-E6/E7 cells with either the U0126 Erk inhibitor or the XAV939 Wnt 353 
inhibitor to suppress phospho-Erk or Wnt/-catenin signaling pathways, 354 
respectively. Interestingly, XAV939 could only inactivate the Wnt/-catenin 355 
signaling pathway but not the Erk signaling pathway, which indicated the Erk 356 
signaling pathway was likely to be an upstream regulator of Wnt/-catenin 357 
signaling pathway in response to hCG treatment (Fig. 4). 358 
 359 
Estradiol and progesterone together promote the synthesis of LH receptor 360 
in the epithelium of pig oviduct (51, 52). High progesterone level is associated 361 
with a lower Olfm1 expression level during the implantation window in human 362 
endometrium, and suppression of Olfm1 expression enhances spheroid 363 
attachment in OE-E6/E7 cells (36). Therefore, it is likely that steroid hormones 364 
may modulate the effect of embryo-derived hCG in activating hCG/LH receptor 365 
through Erk/Wnt-signaling pathway to suppress Olfm1 expression in the 366 
human Fallopian tube. 367 
 368 
In summary, this study demonstrated the role of hCG in regulating the 369 
attachment of trophoblastic spheroids (blastocyst surrogate) on human 370 
Fallopian tube epithelial cells through activation of Erk and Wnt/-catenin 371 
signaling pathways leading to down-regulation of Olfm1 expression. Our 372 
results suggest that changes in the embryo microenvironment in the Fallopian 373 
tube induced by hCG could predispose to TEP. Further studies will be needed 374 
 to focus on the role of hCG in regulating Erk and Wnt/-catenin expressions in 375 
patients with TEP. 376 
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  557 
 Figure Legend 558 
 559 
Figure 1. Olfm1 and LHCGR expression in Fallopian tubes at different 560 
phases of the menstrual cycle, and effect of hCG treatment on 561 
attachment of JAr spheroids on OE-E6/E7 cells. (A) Expression of Olfm1 562 
and LHCGR in the ampullary region of the Fallopian tube in the follicular (n=5), 563 
periovulatory (n=5), and luteal (n=5) phases of the menstrual cycle. (B) 564 
H-score of Olfm1 and LHCGR in the epithelial cells in ampullary region of the 565 
Fallopian tube. (*p<0.05; Scale bar = 100 µm; Epi: epithelial cells, Stm: stromal 566 
cells, Lmn: lumen). (C) JAr spheroids of about 100 µm in size were co-cultured 567 
with OE-E6/E7 cells. (D) Effect of hCG (range, 0 - 25 IU/mL) on spheroid 568 
attachment on OE-E6/E7 cells at 1 h co-culture. Top panel represents 569 
treatment on OE-E6/E7 cells only, middle panel represents treatment on 570 
trophoblastic JAr cells only, and bottom panel represents treatment on both 571 
trophoblastic JAr and OE-E6/E7 cells. (* p<0.05 compared to control) 572 
 573 
Figure 2. hCG down-regulated Olfm-1 and Axin2 but up-regulated active 574 
β-catenin expression in OE-E6/E7 cells. (A) hCG (2.5 and 25 IU/mL) 575 
down-regulated Olfm1 expression but not LHCGR expression in OE-E6/E7 576 
cells. (B) hCG (25 IU/mL) down-regulated Olfm1 expression in primary 577 
Fallopian epithelial cells isolated from Fallopian tissue. (C) β-catenin is 578 
expressed in epithelial cells of normal Fallopian tube (top). Embedded image 579 
in the photo was negative control without primary antibodies. Stm: Stromal, 580 
Lmn: Lumen, Epi: epithelium. The expression of active -catenin is 581 
up-regulated by hCG at 25 IU/mL in primary Fallopian epithelial cells isolated 582 
from Fallopian tissue (middle and bottom). (D) hCG down-regulated Axin2 and 583 
 up-regulated active--catenin in OE-E6/E7 cells. No changes in total β-catenin 584 
and -actin were observed (total β-catenin and -actin were used as controls). 585 
(E) hCG (25 IU/mL) increased TOP/FOP Flash luciferase signaling in 586 
OE-E6/E7 cells indicating activation of the Wnt/β-catenin signaling pathway. (* 587 
p<0.05 compared to control) 588 
 589 
Figure 3. hCG activated both Erk and β-catenin signaling pathways in 590 
OE-E6/E7 cells. (A) hCG (2.5 and 25 IU/mL) up-regulated phospho-Erk in 591 
OE-E6/E7 cells. No changes in phospho-JNK and phospho-p38 were 592 
observed (total-Erk, total-JNK, total-p38 and -actin were used as controls). (B) 593 
hCG increased the spheroid attachment rate, activated Erk and β-catenin 594 
signaling pathways, and down-regulated Olfm1 expression. Treatment with 595 
U0126 Erk signaling pathway inhibitor decreased the spheroid attachment rate, 596 
reduced Erk and β-catenin signaling pathways, and up-regulated Olfm1 597 
expression. Treatment with XAV939 Wnt/β-catenin signaling inhibitor 598 
decreased the spheroid attachment rate, suppressed the β-catenin but not Erk 599 
signaling pathway, and up-regulated Olfm1 expression. hCG did not reverse 600 
the suppressive effect on spheroid attachment by XAV939 and U0126. (* 601 
p<0.05 compared to control) 602 
 603 
Figure 4. The role of hCG in tubal ectopic pregnancy. Embryonic hCG 604 
activated Erk and Wnt/β-catenin signaling pathways in Fallopian tube epithelial 605 
cells through LHCGR causing down-regulation of Olfm1. Aberrant high levels 606 
of hCG may promote attachment of the embryo on Fallopian tube epithelial 607 
cells leading to tubal ectopic pregnancy. 608 
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